Mksap general internal - Study guides, Class notes & Summaries

MKSAP - General Internal Medicine Actual Questions and Answers 2024/2025 with complete solution How does the ACC/AHA define severe LDL 190+ Per ACC/AHA recommendations patients that are 20 years or older with LDL 190+ should be treated with maximum tolerated statin therapy for primary prevention of ASCVD regardles of the 10 year ASCVD risk score Per the USPSTF adults aged 40-75 without a hx of ASCVD who have 1 or more traditional risk factor AND a calculated 10 year ASCVD event risk of 10...

MKSAP - General Internal Medicine Actual Questions and Answers 2024/2025 with complete solution How does the ACC/AHA define severe LDL 190+ Per ACC/AHA recommendations patients that are 20 years or older with LDL 190+ should be treated with maximum tolerated statin therapy for primary prevention of ASCVD regardles of the 10 year ASCVD risk score Per the USPSTF adults aged 40-75 without a hx of ASCVD who have 1 or more traditional risk factor AND a calculated 10 year ASCVD event risk of 10...

MKSAP - General Internal Medicine Actual Questions and Answers 2024/2025 with complete solution How does the ACC/AHA define severe LDL 190+ Per ACC/AHA recommendations patients that are 20 years or older with LDL 190+ should be treated with maximum tolerated statin therapy for primary prevention of ASCVD regardles of the 10 year ASCVD risk score Per the USPSTF adults aged 40-75 without a hx of ASCVD who have 1 or more traditional risk factor AND a calculated 10 year ASCVD event risk of 10...

The American College of Cardiology and American Heart Association recommend that patients aged 21 years or older with an LDL cholesterol level of 190 mg/dL (4.92 mmol/L) or higher should receive ___ for primary prevention of atherosclerotic cardiovascular disease. - ANS high-intensity statin therapy - atorvastatin - rosuvastatin When should screening mammography be started? - ANS 50 up to age 74 - biennial screening For patients undergoing orthopedic surgery without ...